Tác động của việc bổ sung lutein trong 1 năm đối với mật độ quang học của sắc tố hoàng điểm và chức năng thị giác

Handelman GJ, Dratz EA, Reay CC, van Kuijk JG (1988) Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 29:850–855 Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531–1535 Snodderly DM, Auran JD, Delori FC (1984) The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 25:674–685 Snodderly DM, Brown PK, Delori FC, Auran JD (1984) The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 25:660–673 Bone RA, Landrum JT, Cains A (1992) Optical density spectra of the macular pigment in vivo and in vitro. Vision Res 32:105–110 Beatty S, Koh H, Phil M, Henson D, Boulton M (2000) The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 45:115–134 Beatty S, Boulton M, Henson D, Koh HH, Murray IJ (1999) Macular pigment and age-related macular degeneration. Br J Ophthalmol 83:867–877 Landrum JT, Bone RA, Kilburn MD (1997) The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 38:537–556 Khachik F, Bernstein PS, Garland DL (1997) Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 38:1802–1811 LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R (2008) Macular pigment density and age-related maculopathy in the carotenoids in Age-Related Eye Disease Study. An ancillary study of the women’s health initiative. Ophthalmology 115(876–883):e1 Nolan JM, Stack J, O’Donovan O, Loane E, Beatty S (2007) Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res 84:61–74 Obana A, Hiramitsu T, Gohto Y, Ohira A, Mizuno S, Hirano T, Bernstein PS, Fujii H, Iseki K, Tanito M, Hotta Y (2008) Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology 115:147–157 Coleman H, Chew E (2007) Nutritional supplementation in age-related macular degeneration. Curr Opin Ophthalmol 18:220–223 Mares-Perlman JA, Fisher AI, Klein R, Palta M, Block G, Millen AE, Wright JD (2001) Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 153:424–432 Sasamoto Y, Gomi F, Sawa M, Tsujikawa M, Hamasaki T (2010) Macular pigment optical density in central serous chorioretinopathy. Invest Ophthalmol Vis Sci 51:5219–5225 Christen WG, Ajani UA, Glynn RJ, Manson JE, Schaumberg DA, Chew EC, Buring JE, Hennekens CH (1999) Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol 149:476–484 Group A-REDSR (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol 119:1439–1452 Mares-Perlman JA, Klein R, Klein BE, Greger JL, Brady WE, Palta M, Ritter LL (1996) Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol 114:991–997 Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT et al (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA 272:1413–1420 Hammond BR Jr, Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM (1997) Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 38:1795–1801 Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D (2000) Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 41:3322–3326 Bone RA, Landrum JT (2010) Dose-dependent response of serum lutein and macular pigment optical density to supplementation with lutein esters. Arch Biochem Biophys 504:50–55 Schalch W, Cohn W, Barker FM, Kopcke W, Mellerio J, Bird AC, Robson AG, Fitzke FF, van Kuijk FJ (2007) Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys 458:128–135 Trieschmann M, Beatty S, Nolan JM, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84:718–728 Zeimer M, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D (2009) The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants: The LUNA Study. Ophthalmologe 106:29–36 Bone RA, Landrum JT, Guerra LH, Ruiz CA (2003) Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 133:992–998 Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE (1997) A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res 65:57–62 Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J (2004) Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 75:216–230 Bartlett HE, Eperjesi F (2008) A randomised controlled trial investigating the effect of lutein and antioxidant dietary supplementation on visual function in healthy eyes. Clin Nutr 27:218–227 Hammond BR Jr, Wooten BR, Curran-Celentano J (2001) Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys 385:41–46 Hammond BR Jr, Wooten BR, Snodderly DM (1998) Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci 39:397–406 Kvansakul J, Rodriguez-Carmona M, Edgar DF, Barker FM, Kopcke W, Schalch W, Barbur JL (2006) Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt 26:362–371 Rodriguez-Carmona M, Kvansakul J, Harlow JA, Kopcke W, Schalch W, Barbur JL (2006) The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Ophthalmic Physiol Opt 26:137–147 Stringham JM, Hammond BR (2008) Macular pigment and visual performance under glare conditions. Optom Vis Sci 85:82–88 Uz E, Sahin S, Hepsen IF, Var A, Sogut S, Akyol O (2003) The relationship between serum trace element changes and visual function in heavy smokers. Acta Ophthalmol Scand 81:161–164 Wooten BR, Hammond BR (2002) Macular pigment: influences on visual acuity and visibility. Prog Retin Eye Res 21:225–240 Delori FC (2004) Autofluorescence method to measure macular pigment optical densities fluorometry and autofluorescence imaging. Arch Biochem Biophys 430:156–162 Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18:1212–1230 Trieschmann M, Heimes B, Hense HW, Pauleikhoff D (2006) Macular pigment optical density measurement in autofluorescence imaging: comparison of one- and two-wavelength methods. Graefes Arch Clin Exp Ophthalmol 244:1565–1574 Verdon W, Bullimore M, Maloney RK (1996) Visual performance after photorefractive keratectomy. A prospective study. Arch Ophthalmol 114:1465–1472 Applegate RA, Howland HC, Sharp RP, Cottingham AJ, Yee RW (1998) Corneal aberrations and visual performance after radial keratotomy. J Refract Surg 14:397–407 Midena E, Radin PP, Pilotto E, Ghirlando A, Convento E, Varano M (2004) Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 19:55–61 Sawa M, Gomi F, Toyoda A, Ikuno Y, Fujikado T, Tano Y (2006) A microperimeter that provides fixation pattern and retinal sensitivity measurement. Jpn J Ophthalmol 50:111–115 Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19:716–723 Sasamoto Y, Gomi F, Sawa M, Sakaguchi H, Tsujikawa M, Nishida K (2010) Effect of cataract in evaluation of macular pigment optical density using autofluorescence spectrometry. Invest Ophthalmol Vis Sci 52:927–932 Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10:31 Tan JS, Mitchell P, Smith W, Wang JJ (2007) Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 114:1143–1150 Lachenmayr BJ, Kojetinsky S, Ostermaier N, Angstwurm K, Vivell PM, Schaumberger M (1994) The different effects of aging on normal sensitivity in flicker and light-sense perimetry. Invest Ophthalmol Vis Sci 35:2741–2748 Midena E, Vujosevic S, Cavarzeran F (2010) Normal values for fundus perimetry with the microperimeter MP1. Ophthalmology 117:1571–1576, 1576 e